Predictors of cardiovascular events after liver transplantation: A role for pretransplant serum troponin levels

Liver Transplantation

Volumn 17, Issue 1, 2011, Pages 23-31

  Coss, Elizabeth ^a   Watt, Kymberly D S ^a   Pedersen, Rachel ^a   Dierkhising, Ross ^a   Heimbach, Julie K ^a   Charlton, Michael R ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; TROPONIN;

ADULT; AGE; ANAMNESIS; ARTICLE; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENDER; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE WALL; HUMAN; HYPERTENSION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PARAMETER; POSTOPERATIVE COMPLICATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; SMOKING;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; DIABETES COMPLICATIONS; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MINNESOTA; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TROPONIN I; UP-REGULATION;

EID: 79251532081     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.22140     Document Type: Article

References (35)

1. Carey WD, Dumot JA, Pimentel RR, Barnes DS, Hobbs RE, Henderson JM, et al. The prevalence of coronary artery disease in liver transplant candidates over age 50. Transplantation 1995; 59: 859-864.
2. Plotkin JS, Scott VL, Pinna A, Dobsch BP, De Wolf AM, Kang Y., Morbidity and mortality in patients with coronary artery disease undergoing orthotopic liver transplantation. Liver Transpl Surg 1996; 2: 426-430.
3. Dec GW, Kondo N, Farrell ML, Dienstag J, Cosimi AB, Semigran MJ., Cardiovascular complications following liver transplantation. Clin Transplant 1995; 9: 463-471.
4. Diedrich DA, Findlay JY, Harrison BA, Rosen CB., Influence of coronary artery disease on outcomes after liver transplantation. Transplant Proc 2008; 40: 3554-3557.
5. John P, Thuluvath P., Outcome of liver transplantation in patients with diabetes mellitus: a case-control study. Hepatology 2001; 34: 889-895.
6. Bianchi G, Marchesini G, Marzocchi R, Pinna AD, Zoli M., Metabolic syndrome in liver transplantation: relation to etiology and immunosuppression. Liver Transpl 2008; 14: 1648-1654.
7. Reuben A., Long-term management of the liver transplant patient: diabetes, hyperlipidemia, and obesity. Liver Transpl 2001; 7 (11 Suppl 1): S13-S21.
8. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR., Evolution of causes and risk factors for mortality post liver transplant: results of the NIDDK long term follow-up study. Am J Transplant 2010; 10: 1420-1427.
9. Plotkin JS, Johnson LB, Rustgi VK, Kuo PC, Liu AD., Dobutamine stress echocardiography for orthotopic liver transplant evaluation. Transplantation 2001; 71: 818.
10. Moller S, Henriksen JH., Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 2002; 87: 9-15.
11. Therapondos G, Flapan AD, Plevris JN, Hayes PC., Cardiac morbidity and mortality related to orthotopic liver transplantation. Liver Transpl 2004; 10: 1441-1453.
12. Keeffe BG, Valantine H, Keeffe EB., Detection and treatment of coronary artery disease in liver transplant candidates. Liver Transpl 2001; 7: 755-761.
13. Findlay JY, Keegan MT, Pellikka PP, Rosen CB, Plevak DJ., Preoperative dobutamine stress echocardiography, intraoperative events, and intraoperative myocardial injury in liver transplantation. Transplant Proc 2005; 37: 2209-2213.
14. Umphrey LG, Hurst RT, Eleid MF, Lee KS, Reuss CS, Hentz JG, et al. Preoperative dobutamine stress echocardiographic findings and subsequent short-term adverse cardiac events after orthotopic liver transplantation. Liver Transpl 2008; 14: 886-892.
15. Jaffe AS, Babuin L, Apple FS., Biomarkers in acute cardiac disease: the present and the future. J Am Coll Cardiol 2006; 48: 1-11.
16. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009; 361: 868-877.
17. Brekke P, Omland T, Holmedal S, Smith P, Søyseth V., Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation. Eur Respir J 2008; 31: 563-570.
18. Apple FS, Murakami MM, Pearce LA, Herzog CA., Predictive value of cardiac troponin I and T for subsequent death in end-stage renal disease. Circulation 2002; 106: 2941-2945.
19. Becattini C, Vedovati M, Agnelli G., Prognostic value of troponins in acute pulmonary embolism: a meta-analysis. Circulation 2007; 116: 427-433.
20. Pateron D, Beyne P, Laperche T, Logeard D, Lefilliatre P, Sogni P, et al. Elevated circulating cardiac troponin I in patients with cirrhosis. Hepatology 1999; 29: 640-643.
21. Parekh NK, Hynan LS, De Lemos J, Lee WM., Elevated troponin I levels in acute liver failure: is myocardial injury an integral part of acute liver failure? Hepatology 2007; 45: 1489-1495.
22. Watt K, Coss E, Pedersen R, Dierkhising R, Heimbach J, Charlton M., Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation [abstract]. Liver Transpl 2009; 15: S100.
23. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Sr, Wilson PW., C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham Offspring Study. Circulation 2004; 110: 380-385.
24. Alqahtani SA, Fouad TR, Lee SS., Cirrhotic cardiomyopathy. Semin Liver Dis 2008; 28: 59-69.
25. Park SC, Beerman LB, Gartner JC, Zitelli BJ, Malatack JJ, Fricker FJ, et al. Echocardiographic findings before and after liver transplantation. Am J Cardiol 1985; 55: 1373-1378.
26. Piscaglia F, Zironi G, Gaiani S, Mazziotti A, Cavallari A, Gramantieri L, et al. Systemic and splanchnic hemodynamic changes after liver transplantation for cirrhosis: a long-term prospective study. Hepatology 1999; 30: 58-64.
27. Safadi A, Homsi M, Maskoun W, Lane KA, Singh I, Sawada SG, Mahenthiran J., Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery. Circulation 2009; 120: 1189-1194.
28. Volk ML, Hernandez JC, Lok AS, Marrero JA., Modified Charlson comorbidity index for predicting survival after liver transplantation. Liver Transpl 2007; 13: 1515-1520.
29. Fouad TR, Abdel-Razek WM, Burak KW, Bain VG, Lee SS., Prediction of cardiac complications after liver transplantation. Transplantation 2009; 87: 763-770.
30. Kanwar M, Hashem M, Rosman H, Kamalakannan D, Cheema A, Ali A, et al. Usefulness of clinical evaluation, troponins, and C-reactive protein in predicting mortality among stable hemodialysis patients. Am J Cardiol 2006; 98: 1283-1287.
31. Nagaoka S, Yoshida T, Akiyoshi J, Akiba J, Torimura T, Adachi H, et al. Serum C-reactive protein levels predict survival in hepatocellular carcinoma. Liver Int 2007; 27: 1091-1097.
32. Bradley SM, Soine LA, Caldwell JH, Goldberg SL., Screening stress myocardial perfusion imaging and eligibility for liver transplantation. Am J Cardiol 2010; 105: 1010-1013.
33. Little WC., Angiographic assessment of the culprit coronary artery lesion before acute myocardial infarction. Am J Cardiol 1990; 66: 44G-47G.
34. Monaco M, Stassano P, Di Tommaso L, Pepino P, Giordano A, Pinna GB, et al. Systematic strategy of prophylactic coronary angiography improves long-term outcome after major vascular surgery in medium- to high-risk patients: a prospective, randomized study. J Am Coll Cardiol 2009; 54: 989-996.
35. Eimer MJ, Wright JM, Wang EC, Kulik L, Blei A, Flamm S, et al. Frequency and significance of acute heart failure following liver transplantation. Am J Cardiol 2008; 101: 242-244.